We are here to provide that remarkable patient experience. To improve patient retention in clinical trials, individuals have to feel comfortable.

Dr Arthur Lazarus joined mdgroup as Medical Director in July 2021. After practising as a psychiatrist delivering one-to-one care for 20 years, he became interested in population health care and global impact, which led him first to a career in health insurance and then to the pharmaceutical industry.  Dr Lazarus has been referred to as […]

As our network of nurses continues to grow, we are facilitating more decentralised trials and carrying out an ever-increasing number of clinical trial visits to patients in their own homes.

Passionate about putting the patient at the heart of everything we do, LaQuinta shares what she has learnt through the challenges of the pandemic, what she thinks sets us apart from our competitors, and what exciting developments we can expect to see for the company in 2021.

Our Chief Operating Officer, Christopher Kennedy, recently presented at Pharma and Patient USA, a virtual event bringing together leaders in patient-centricity. Christopher shared our perspective on what it takes to deliver remarkable patient experiences to clinical trial participants.

The 21st Century Cures Act was nothing short of revolutionary. Signed into U.S. law on December 13th 2016, it is designed to support the acceleration of medical product development and bring new innovations and advances to patients who need them (FDA.com).